The global pharmaceutical landscape is increasingly focusing on highly specialized nutrient intermediates to address complex metabolic disorders. Among these, the integration of high-purity chemical precursors, often referenced in industrial databases by identifiers like cas no 96 31 1, underscores the necessity for precision in molecular synthesis to ensure therapeutic efficacy and patient safety.
Understanding the chemical properties and manufacturing standards of pharmaceutical intermediates is crucial for developers aiming to create stable, bioavailable formulations. Whether dealing with ketogenic amino acids or specialized API precursors, the industry relies on stringent quality control measures to bridge the gap between raw chemical synthesis and clinical application.
By analyzing the intersection of chemical purity and regulatory compliance, stakeholders can optimize the production of essential medicinal components. This discourse explores the significance of these intermediates, focusing on how standardized identifiers and GMP-certified production processes ensure the reliability of the global medical supply chain.
The Chemical Essence of D,L-α-Ketoisoleucine Calcium
D,L-α-Ketoisoleucine Calcium is a critical pharmaceutical intermediate characterized by its molecular formula C12H18CaO6. Within the context of chemical sourcing, where users often search for precise identifiers like cas no 96 31 1, this compound stands out as a vital component in the synthesis of nutritional supplements and specialized medicinal treatments.
The substance appears as a white or almost white crystal powder with a distinct bitter taste, reflecting its high purity and concentrated chemical nature. Its role as a calcium salt of a keto-analogue makes it highly stable, allowing for precise dosing in complex pharmaceutical formulations.
Regulatory Standards and GMP Compliance for cas no 96 31 1
In the modern pharmaceutical industry, the transition from a raw chemical to a clinical-grade ingredient requires strict adherence to international standards. The production of intermediates related to cas no 96 31 1 must align with Good Manufacturing Practices (GMP) to ensure that every batch is consistent, pure, and free from contaminants.
Approval by the CFDA (China Food and Drug Administration) further validates the safety and efficacy of D,L-α-Ketoisoleucine Calcium. This regulatory oversight ensures that the material meets the rigorous demands of the pharmaceutical market, providing clinicians with the confidence that the starting materials are synthesized under controlled environment.
Beyond certification, the maintenance of comprehensive documentation—including Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS)—is essential. This transparency allows global buyers to verify the authenticity and quality of the compound, minimizing risks in the drug development pipeline.
Technical Specifications and Molecular Integrity
The molecular integrity of D,L-α-Ketoisoleucine Calcium is defined by its molecular weight of 298.35 and its specific structural formula. For researchers tracking chemicals via cas no 96 31 1, the focus is often on the purity level, which for this premium grade ranges strictly between 98.5% and 102.0%.
Achieving a content range of 98.5%-102.0% requires advanced crystallization techniques and rigorous filtration processes. This level of precision prevents the presence of unwanted isomers or residual solvents, which could otherwise compromise the stability of the final pharmaceutical product.
The physical characteristics—specifically the crystal powder form—are optimized for solubility and blending. This ensures that when the compound is integrated into a larger API (Active Pharmaceutical Ingredient) framework, it distributes evenly, preventing "hot spots" of concentration in the final dosage form.
Industrial Performance and Purity Metrics
When evaluating the efficiency of pharmaceutical intermediates, industry experts look at purity markers and stability indices. The performance of materials associated with cas no 96 31 1 is measured by their ability to maintain chemical potency over extended storage periods without degradation.
The following data illustrates the relative performance ratings of various purity grades and synthesis methods used in the production of keto-analogues, emphasizing the superiority of GMP-certified calcium salts.
Purity and Stability Metrics for cas no 96 31 1 Grade Variants
Global Application in Pharmaceutical Intermediates
D,L-α-Ketoisoleucine Calcium finds extensive use in the production of specialized nutritional infusions and metabolic therapy medications. By serving as a stable precursor, it allows pharmaceutical companies to synthesize treatments for patients with specific amino acid metabolism disorders, where traditional protein intake must be strictly limited.
The global demand for high-quality intermediates, often identified under cas no 96 31 1, spans across Europe, North America, and Asia. In these regions, the compound is integrated into Parenteral Nutrition (PN) solutions and specialized dietary supplements designed for chronic kidney disease (CKD) management.
Logistics and Stability in Bulk Packaging
The physical stability of D,L-α-Ketoisoleucine Calcium is heavily dependent on its packaging environment. To prevent moisture absorption and oxidative degradation, the product is packaged in multi-layer craft paper drums. This robust outer shell protects the material during international transit, ensuring that the purity remains within the 98.5%-102.0% range.
Inside the drum, a food-grade PE inner bag provides a primary barrier against contaminants, while an additional shading inner bag protects the chemical structure from UV-induced degradation. This triple-layer protection is a standard requirement for chemicals that share the sensitivity profile of cas no 96 31 1.
With a standard specification of 25kg per drum, the logistics chain is optimized for industrial-scale pharmaceutical manufacturing. This bulk formatting reduces waste and ensures a consistent supply for large-scale API production lines.
Comparative Analysis of Keto-Analogues
Comparing D,L-α-Ketoisoleucine Calcium with other keto-analogues reveals its unique position in terms of solubility and metabolic utility. While all keto-analogues serve to provide essential nitrogen-free precursors, the calcium salt form of this specific compound offers superior stability in aqueous solutions compared to sodium salts.
Industry professionals analyzing cas no 96 31 1 often prioritize the "bitter taste" and "white crystal" morphology as primary indicators of authenticity during the initial reception of raw materials. These sensory and physical markers, combined with laboratory titration, confirm the product's identity before it enters the synthesis phase.
The long-term value of choosing a GMP-certified intermediate lies in the reduction of batch failures. By ensuring the starting material is precisely within the specified chemical parameters, manufacturers can achieve higher yields and lower purification costs in the final stage of drug production.
Comprehensive Comparison of Keto-Analogue Specifications
| Chemical Variant |
Purity Level |
Stability Score (1-10) |
Regulatory Status |
| D,L-α-Ketoisoleucine Ca |
98.5% - 102.0% |
9.8 |
CFDA/GMP Approved |
| Keto-Leucine Salt |
97.0% - 99.0% |
8.5 |
Industrial Grade |
| Keto-Valine Calcium |
98.0% - 101.0% |
9.2 |
GMP Certified |
| Standard Keto-Mix |
95.0% - 98.0% |
7.0 |
General Use |
| L-Isoluecine Base |
99.0% - 100.0% |
8.0 |
API Grade |
| Refined Keto-Analog |
98.2% - 99.5% |
8.8 |
ISO Certified |
FAQS
The standard purity for premium grade D,L-α-Ketoisoleucine Calcium is strictly maintained between 98.5% and 102.0%. This range is verified through rigorous testing to ensure it meets the requirements for pharmaceutical intermediates, such as those sought under cas no 96 31 1, ensuring optimal stability and efficacy in clinical applications.
Yes, this product is approved by CFDA and holds GMP certification. This means it is manufactured under strict quality control protocols that monitor every stage of production, from raw material sourcing to final packaging, ensuring the final powder is suitable for pharmaceutical use.
To maintain the high purity levels associated with cas no 96 31 1, the product is packed in multi-layer craft paper drums. It includes a food-grade PE inner bag for contamination prevention and a shading inner bag to protect against light-induced chemical changes, typically in 25kg drums.
It is primarily used in the manufacture of specialized nutritional supplements and pharmaceutical infusions. Specifically, it serves as a critical component in managing patients with amino acid metabolism disorders and in parenteral nutrition formulations for renal care.
The material should arrive as a white or almost white crystal powder. One of its distinguishing sensory characteristics is a bitter taste. Any deviation from this appearance or taste may indicate a compromise in purity or a mismatch with the expected specifications of cas no 96 31 1.
The calcium salt form provides significantly higher chemical stability and a longer shelf life compared to other salt forms. This ensures that the intermediate remains potent during storage and transportation, reducing the risk of degradation before it is processed into the final medication.
Conclusion
D,L-α-Ketoisoleucine Calcium represents a pinnacle of precision in the manufacture of pharmaceutical intermediates. By combining a high purity range of 98.5%-102.0% with strict GMP and CFDA certifications, it provides the essential stability and reliability required for critical nutritional and metabolic therapies. The careful integration of advanced packaging—utilizing shading and food-grade liners—further ensures that the chemical integrity of the compound, often identified by cas no 96 31 1, is preserved from the factory to the final formulation.
As the pharmaceutical industry moves toward more personalized medicine and targeted nutritional support, the demand for such high-specification intermediates will only grow. We recommend that procurement officers and researchers prioritize GMP-certified sources to ensure batch-to-batch consistency and regulatory compliance. For more information on high-purity intermediates and API precursors, visit our website: www.kxdchem.com.
